4.7 Article

Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing

Journal

JOURNAL OF NEUROSCIENCE
Volume 32, Issue 4, Pages 1467-1480

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2272-11.2012

Keywords

-

Categories

Funding

  1. Lundbeck Foundation
  2. Alzheimer's Association [NIRG-08-89450]
  3. Novo Nordic Foundation
  4. Alzheimerforskningsfonden
  5. Carlsberg Foundation
  6. Augustinus Foundation
  7. Villum Foundation
  8. Danish Medical Research Council
  9. Aase and Ejnar Danielsen Foundation
  10. Medical Research Council
  11. MRC [G0700750] Funding Source: UKRI
  12. Lundbeck Foundation [R54-2010-5281] Funding Source: researchfish
  13. Medical Research Council [G0700750] Funding Source: researchfish

Ask authors/readers for more resources

sorLA is a sorting receptor for amyloid precursor protein (APP) genetically linked to Alzheimer's disease (AD). Retromer, an adaptor complex in the endosome-to-Golgi retrieval pathway, has been implicated in APP transport because retromer deficiency leads to aberrant APP sorting and processing and levels of retromer proteins are altered in AD. Here we report that sorLA and retromer functionally interact in neurons to control trafficking and amyloidogenic processing of APP. We have identified a sequence (FANSHY) in the cytoplasmic domain of sorLA that is recognized by the VPS26 subunit of the retromer complex. Accordingly, we characterized the interaction between the retromer complex and sorLA and determined the role of retromer on sorLA-dependent sorting and processing of APP. Mutations in the VPS26 binding site resulted in receptor redistribution to the endosomal network, similar to the situation seen in cells with VPS26 knockdown. The sorLA mutant retained APP-binding activity but, as opposed to the wild-type receptor, misdirected APP into a distinct non-Golgi compartment, resulting in increased amyloid processing. In conclusion, our data provide a molecular link between reduced retromer expression and increased amyloidogenesis as seen in patients with sporadic AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available